Federal award
WERFEN USA LLC
W81K0221P0034
Contract
Obligated and Ceiling
- Obligated (net)
- $74,645.82
- Ceiling (potential value, not spending)
- $74,645.82
- Current value
- $74,645.82
- Gross positive obligations
- $184,578.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- WERFEN USA LLC · JA87HT8KP2M2
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- WERFEN ESPANA SA · VL62U6FBHHZ3
- Awarding agency
- Department of War · sub-agency 2100 · office W81K02
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0221P0034
- Award type code
- B
- Actions
- 9 · Dec 17, 2020 to Apr 20, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 20, 2023 | FY2023 | P00008 | C | −$30,000.00 | — |
| Jan 31, 2023 | FY2023 | P00007 | C | −$79,932.18 | — |
| Oct 13, 2022 | FY2023 | P00006 | C | $61,526.00 | — |
| Feb 10, 2022 | FY2022 | P00005 | G | $0.00 | — |
| Jan 26, 2022 | FY2022 | P00004 | B | $0.00 | — |
| Oct 13, 2021 | FY2022 | P00003 | C | $61,526.00 | — |
| Aug 10, 2021 | FY2021 | P00002 | G | $0.00 | — |
| Jan 20, 2021 | FY2021 | P00001 | C | $61,526.00 | — |
| Dec 17, 2020 | FY2021 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.